|
ZNF263 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.00560000116224E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85904999999709E-05 |
| Normal-vs-Stage2 |
1.975660E-02 |
| Normal-vs-Stage3 |
3.340500E-03 |
| Normal-vs-Stage4 |
4.788100E-02 |
| Stage1-vs-Stage2 |
8.143000E-01 |
| Stage1-vs-Stage3 |
3.438800E-01 |
| Stage1-vs-Stage4 |
4.705800E-01 |
| Stage2-vs-Stage3 |
6.731800E-01 |
| Stage2-vs-Stage4 |
6.871200E-01 |
| Stage3-vs-Stage4 |
9.531600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.37180000481641E-09 |
| Normal-vs-AfricanAmerican |
1.340240E-03 |
| Normal-vs-Asian |
5.213200E-01 |
| Caucasian-vs-AfricanAmerican |
5.995900E-02 |
| Caucasian-vs-Asian |
2.932600E-01 |
| AfricanAmerican-vs-Asian |
6.512200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3025000000777E-07 |
| Normal-vs-Female |
4.74829999996818E-06 |
| Male-vs-Female |
7.667600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.217300E-03 |
| Normal-vs-Extreme_Weight |
4.09420000002658E-06 |
| Normal-vs-Obese |
4.63210000001268E-06 |
| Normal-vs-Extreme_Obese |
4.164600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.081800E-01 |
| Normal_Weight-vs-Obese |
6.370400E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.338400E-01 |
| Extreme_Weight-vs-Obese |
2.297800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.079800E-01 |
| Obese-vs-Extreme_Obese |
1.512020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.88220000002715E-06 |
| Normal-vs-Age(41-60Yrs) |
5.60709999986031E-07 |
| Normal-vs-Age(61-80Yrs) |
6.63250000032534E-07 |
| Normal-vs-Age(81-100Yrs) |
1.991410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.030400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.780400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.347600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.765600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.207400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.563800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.31680000237111E-10 |
| Normal-VS-Type2 PRCC |
1.276770E-01 |
| Normal-VS-KIRP CIMP |
2.99100000322738E-08 |
| Normal-VS-Unclassified PRCC |
7.422300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.79139999968126E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.268300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.341760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.353240E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.247900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.005900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.985800E-02 |
| Normal-vs-N1 |
1.164300E-04 |
| Normal-vs-N2 |
2.204600E-01 |
| N0-vs-N1 |
4.461800E-03 |
| N0-vs-N2 |
1.410170E-01 |
| N1-vs-N2 |
9.614200E-01 |
|
|
